Co-culture of human induced pluripotent stem cell-derived retinal pigment epithelial cells and endothelial cells on double collagen-coated honeycomb films.


Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 09 08 2019
revised: 25 10 2019
accepted: 01 11 2019
pubmed: 13 11 2019
medline: 6 1 2021
entrez: 13 11 2019
Statut: ppublish

Résumé

In vitro cell culture models representing the physiological and pathological features of the outer retina are urgently needed. Artificial tissue replacements for patients suffering from degenerative retinal diseases are similarly in great demand. Here, we developed a co-culture system based solely on the use of human induced pluripotent stem cell (hiPSC)-derived cells. For the first time, hiPSC-derived retinal pigment epithelium (RPE) and endothelial cells (EC) were cultured on opposite sides of porous polylactide substrates prepared by breath figures (BF), where both surfaces had been collagen-coated by Langmuir-Schaefer (LS) technology. Small modifications of casting conditions during material preparation allowed the production of free-standing materials with distinct porosity, wettability and ion diffusion capacity. Complete pore coverage was achieved by the collagen coating procedure, resulting in a detectable nanoscale topography. Primary retinal endothelial cells (ACBRI181) and umbilical cord vein endothelial cells (hUVEC) were utilised as EC references. Mono-cultures of all ECs were prepared for comparison. All tested materials supported cell attachment and growth. In mono-culture, properties of the materials had a major effect on the growth of all ECs. In co-culture, the presence of hiPSC-RPE affected the primary ECs more significantly than hiPSC-EC. In consistency, hiPSC-RPE were also less affected by hiPSC-EC than by the primary ECs. Finally, our results show that the modulation of the porosity of the materials can promote or prevent EC migration. In short, we showed that the behaviour of the cells is highly dependent on the three main variables of the study: the presence of a second cell type in co-culture, the source of endothelial cells and the biomaterial properties. The combination of BF and LS methodologies is a powerful strategy to develop thin but stable materials enabling cell growth and modulation of cell-cell contact. STATEMENT OF SIGNIFICANCE: Artificial blood-retinal barriers (BRB), mimicking the interface at the back of the eye, are urgently needed as physiological and disease models, and for tissue transplantation targeting patients suffering from degenerative retinal diseases. Here, we developed a new co-culture model based on thin, biodegradable porous films, coated on both sides with collagen, one of the main components of the natural BRB, and cultivated endothelial and retinal pigment epithelial cells on opposite sides of the films, forming a three-layer structure. Importantly, our hiPSC-EC and hiPSC-RPE co-culture model is the first to exclusively use human induced pluripotent stem cells as cell source, which have been widely regarded as an practical candidate for therapeutic applications in regenerative medicine.

Identifiants

pubmed: 31711900
pii: S1742-7061(19)30742-1
doi: 10.1016/j.actbio.2019.11.002
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Water 059QF0KO0R
Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-343

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Maria Teresa Calejo (MT)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Electronic address: teresa.rebelocalejo@tuni.fi.

Jaakko Saari (J)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Hanna Vuorenpää (H)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Elina Vuorimaa-Laukkanen (E)

Faculty of Engineering and Natural Sciences, Tampere University, Tampere, Finland.

Pasi Kallio (P)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Katriina Aalto-Setälä (K)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Heart Hospital, Tampere University Hospital, Tampere, Finland.

Susanna Miettinen (S)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland.

Heli Skottman (H)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Minna Kellomäki (M)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Kati Juuti-Uusitalo (K)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH